MGI Tech
NgeneBio Partners With MGI Tech on Precision Cancer Diagnostics
The South Korean NGS diagnostic firm will combine its cancer diagnostic tests with MGI’s DNBSeq-G99 sequencer to expand its global commercial presence.
Invivoscribe, Complete Genomics Partner to Develop, Commercialize Oncology Biomarker Tests
The companies will collaborate to develop biomarkers tests for minimal residual disease (MRDs) in research and clinical setting using the DNBSeq sequencer.
MGI Tech Gets CE Mark for DNBSeq-G99 Sequencer Under New EU IVDR Framework
The CE mark allows the Chinese NGS instrument maker to roll out its new platform in the EU and other countries that accept the designation.
MGI Tech, Burning Rock Biotech Join Forces to Develop Precision Oncology Products
The two Chinese companies recently formed a strategic partnership to develop oncology products and services using MGI's DNBSeq technology.
Ares Genetics Collaborates With BGI on Coronavirus Testing in Europe
A subsidiary of Curetis, a firm recently merged with OpGen, Ares will use BGI technology to sequence samples in Europe.